Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) has issued a notice convening its 2026 Second Extraordinary General Meeting (EGM) for 14:00 on Thursday, 12 November 2026, at the company’s headquarters in Zhuhai, Guangdong Province.
Key matters up for shareholder vote:
1. Board composition • Appointment of Ms Zhu Linlin as a non-executive director. 2. Profit distribution • Ratification of the Profit Distribution Plan for the third quarter of 2026, which includes a cash dividend (the “Quarterly Dividend”) covering the first three quarters of the year. • Record dates: – A-shareholders – end-of-trading on Tuesday, 24 November 2026 (Shenzhen register). – H-shareholders – close of business on Thursday, 26 November 2026 (Hong Kong register). • Currency: Renminbi for A shares; Hong Kong dollars for H shares, converted at the RMB/HKD central parity rate announced on 12 November 2026.
3. Capital return policy • Endorsement of the Shareholder Return Plan for 2026-2028, setting the framework for dividend and repurchase activities over the next three years.
Voting logistics:
• Shareholders registered by Friday, 6 November 2026 are eligible to attend and vote; all resolutions will be decided by poll. • Proxy submissions must reach the company’s Secretariat (A-shares) or Tricor Investor Services (H-shares) at least 24 hours before the meeting.
Tax treatment of the proposed dividend:
• Overseas individual H-shareholders: 20% individual income tax will be withheld and paid by the company. • Non-resident enterprise H-shareholders: 10% corporate income tax will be withheld; eligible shareholders may subsequently apply for treaty-based refunds. • Mainland investors via Southbound Trading Link: – Individuals: 20% individual income tax withheld. – Enterprises: no withholding; tax to be self-declared.
The EGM is expected to last one hour. Shareholders and proxies attending in person will bear their own travel and accommodation expenses.
Comments